Achuthan Sourianarayanane, MD, MRCP, FOMA

Publications

• Liver tissue lipids in metabolic dysfunction-associated steatotic liver disease with diabetes and obesity.

  (Sourianarayanane A, Brydges CR, McCullough AJ.) Clin Res Hepatol Gastroenterol. 2024 Aug;48(7):102402 PMID: 38909684 SCOPUS ID: 2-s2.0-85196779955 06/24/2024

• Liver Tissue Proteins Improve the Accuracy of Plasma Proteins as Biomarkers in Diagnosing Metabolic Dysfunction-Associated Steatohepatitis.

  (Sourianarayanane A, Salemi MR, Phinney BS, McCullough AJ.) Proteomics Clin Appl. 2024 Jul 28:e202300236 PMID: 39073724 SCOPUS ID: 2-s2.0-85200003558 07/29/2024

• Accuracy of steatosis and fibrosis NAFLD scores in relation to vibration controlled transient elastography: An NHANES analysis.

  (Sourianarayanane A, McCullough AJ.) Clin Res Hepatol Gastroenterol. 2022;46(7):101997 PMID: 35842111 SCOPUS ID: 2-s2.0-85135945627 07/17/2022

• Normal hepatic function and physiology

  (Sourianarayanane A.) Hepatic Critical Care. 8 January 2018:3-19 SCOPUS ID: 2-s2.0-85054946429 01/08/2018

• Stage of fibrosis and portal pressure correlation in nonalcoholic steatohepatitis.

  (Sourianarayanane A, Talluri J, Humar A, McCullough AJ.) Eur J Gastroenterol Hepatol. 2017 May;29(5):516-523 PMID: 28079667 SCOPUS ID: 2-s2.0-85009376178 01/13/2017

• Nonalcoholic steatohepatitis recurrence and rate of fibrosis progression following liver transplantation.

  (Sourianarayanane A, Arikapudi S, McCullough AJ, Humar A.) Eur J Gastroenterol Hepatol. 2017 Apr;29(4):481-487 PMID: 28253211 SCOPUS ID: 2-s2.0-85014405487 03/03/2017

• Renal dysfunction in cirrhosis: pathophysiology, diagnosis, and management.

  (Sourianarayanane A, Thandassery RB.) Minerva Gastroenterol Dietol. 2016 Jun;62(2):183-96 PMID: 26731680 SCOPUS ID: 2-s2.0-84975029717 01/06/2016

• The development of a non-invasive model to predict the presence of non-alcoholic steatohepatitis in patients with non-alcoholic fatty liver disease.

  (Goh GB, Issa D, Lopez R, Dasarathy S, Dasarathy J, Sargent R, Hawkins C, Pai RK, Yerian L, Khiyami A, Pagadala MR, Sourianarayanane A, Alkhouri N, McCullough AJ.) J Gastroenterol Hepatol. 2016 May;31(5):995-1000 PMID: 26589761 SCOPUS ID: 2-s2.0-84964515442 11/22/2015

• A prospective analysis of factors associated with decreased physical activity in patients with cirrhosis undergoing transplant evaluation.

  (Dela Cruz AC, Vilchez V, Kim S, Barnes B, Ravinuthala A, Zanni A, Galuppo R, Sourianarayanane A, Patel T, Maynard E, Shah MB, Daily MF, Uhl T, Esser K, Gedaly R.) Clin Transplant. 2015 Nov;29(11):958-64 PMID: 26263921 PMCID: PMC4624476 SCOPUS ID: 2-s2.0-84945460081 08/13/2015

• Clinical spectrum of non-alcoholic fatty liver disease in diabetic and non-diabetic patients.

  (Goh GB, Pagadala MR, Dasarathy J, Unalp-Arida A, Sargent R, Hawkins C, Sourianarayanane A, Khiyami A, Yerian L, Pai RK, Dasarathy S, McCullough AJ.) BBA Clin. 2015 Jun;3:141-5 PMID: 26675585 PMCID: PMC4661498 12/18/2015

• Age impacts ability of aspartate-alanine aminotransferase ratio to predict advanced fibrosis in nonalcoholic Fatty liver disease.

  (Goh GB, Pagadala MR, Dasarathy J, Unalp-Arida A, Pai RK, Yerian L, Khiyami A, Sourianarayanane A, Sargent R, Hawkins C, Dasarathy S, McCullough AJ.) Dig Dis Sci. 2015 Jun;60(6):1825-31 PMID: 25708897 SCOPUS ID: 2-s2.0-84930376071 02/25/2015

• Role of transplantation in the treatment of benign solid tumors of the liver: a review of the United Network of Organ Sharing data set.

  (Sundar Alagusundaramoorthy S, Vilchez V, Zanni A, Sourianarayanane A, Maynard E, Shah M, Daily MF, Pena LR, Gedaly R.) JAMA Surg. 2015 Apr;150(4):337-42 PMID: 25714928 SCOPUS ID: 2-s2.0-84928141061 02/26/2015